Volume 18, Number 5—May 2012
Research
No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
Salaheddin M. Mahmud
, Paul Van Caeseele, Gregory Hammond, Carol Kurbis, Tim Hilderman, and Lawrence Elliott
, Paul Van Caeseele, Gregory Hammond, Carol Kurbis, Tim Hilderman, and Lawrence ElliottTable 6
Demographic and clinical characteristics of case-patients and controls in a study of the association between the 2008–09 TIV and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009*
| Characteristic | No (%) study participants, by age group, y |
|||||
|---|---|---|---|---|---|---|
| <12 | 12–19 | 20–34 | 35–44 | 45–64 | >65 | |
| Community controls | ||||||
| Total | 381 (15.4) | 242 (9.8) | 553 (22.3) | 384 (15.5) | 638 (25.7) | 281 (11.3) |
| Female sex | 185 (48.6) | 138 (57.0) | 353 (63.8) | 237 (61.7) | 385 (60.3) | 170 (60.5) |
| Chronic disease | 30 (7.9) | 21 (8.7) | 57 (10.3) | 74 (19.3) | 203 (31.8) | 163 (58.0) |
| Receipt of 2007–08 TIV | 34 (8.9) | 19 (7.9) | 76 (13.7) | 67 (17.4) | 187 (29.3) | 161 (57.3) |
| Receipt of 2008–09 TIV | 53 (13.9) | 20 (8.3) | 80 (14.5) | 72 (18.8) | 179 (28.1) | 160 (56.9) |
| Community case-patients | ||||||
| Total | 180 (28.8) | 105 (16.8) | 154 (24.6) | 76 (12.1) | 102 (16.3) | 9 (1.4) |
| Female sex | 88 (48.9) | 50 (47.6) | 81 (52.6) | 39 (51.3) | 58 (56.9) | 6 (66.7) |
| Chronic disease | 9 (5.0) | 15 (14.3) | 17 (11.0) | 13 (17.1) | 29 (28.4) | 7 (77.8) |
| Receipt of 2007–08 TIV | 26 (14.4) | 9 (8.6) | 24 (15.6) | 21 (27.6) | 35 (34.3) | 8 (88.9) |
| Receipt of 2008–09 TIV | 24 (13.3) | 10 (9.5) | 20 (13.0) | 15 (19.7) | 34 (33.3) | 6 (66.7) |
| Hospitalized case-patients | ||||||
| Total | 68 (33.2) | 21 (10.2) | 44 (21.5) | 25 (12.2) | 37 (18.0) | 10 (4.9) |
| Female sex | 23 (33.8) | 13 (61.9) | 32 (72.7) | 12 (48.0) | 27 (73.0) | 8 (80.0) |
| Chronic disease | 17 (25.0) | 5 (23.8) | 10 (22.7) | 13 (52.0) | 25 (67.6) | 8 (80.0) |
| Receipt of 2007–08 TIV | 6 (8.8) | 0 (0.0) | 4 (9.1) | 9 (36.0) | 12 (32.4) | 6 (60.0) |
| Receipt of 2008–09 TIV | 9 (13.2) | 3 (14.3) | 4 (9.1) | 5 (20.0) | 14 (37.8) | 4 (40.0) |
*TIV, inactivated trivalent influenza vaccine.
